Joaquim José Coutinho Ferreira
AuthID: R-000-7JF
381
TITLE: Opicapone for the management of end-of-dose motor fluctuations in patients with Parkinson's disease treated with L-DOPA
AUTHORS: Lees, AJ; Ferreira, J; Rascol, O; Reichmann, H; Stocchi, F; Tolosa, E; Poewe, W;
PUBLISHED: 2017, SOURCE: EXPERT REVIEW OF NEUROTHERAPEUTICS, VOLUME: 17, ISSUE: 7
AUTHORS: Lees, AJ; Ferreira, J; Rascol, O; Reichmann, H; Stocchi, F; Tolosa, E; Poewe, W;
PUBLISHED: 2017, SOURCE: EXPERT REVIEW OF NEUROTHERAPEUTICS, VOLUME: 17, ISSUE: 7
382
TITLE: PLACEBO AND NOCEBO RESPONSES IN RLS: A META-ANALYSIS
AUTHORS: Rodrigues, FB; Duarte, GS; Silva, MA; Fernandes, RM; Abreu, D; Mestre, T; Costa, J; Trenkwalder, C; Ferreira, JJ;
PUBLISHED: 2017, SOURCE: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, VOLUME: 88, ISSUE: Suppl 1
AUTHORS: Rodrigues, FB; Duarte, GS; Silva, MA; Fernandes, RM; Abreu, D; Mestre, T; Costa, J; Trenkwalder, C; Ferreira, JJ;
PUBLISHED: 2017, SOURCE: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, VOLUME: 88, ISSUE: Suppl 1
383
TITLE: Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease
AUTHORS: Fabbri, M; Reimao, S; Carvalho, M; Nunes, RG; Abreu, D; Guedes, LC; Bouça, R; Lobo, PP; Godinho, C; Coelho, M; Gonçalves, NC; Rosa, MM; Antonini, A; Ferreira, JJ;
PUBLISHED: 2017, SOURCE: JOURNAL OF PARKINSONS DISEASE, VOLUME: 7, ISSUE: 3
AUTHORS: Fabbri, M; Reimao, S; Carvalho, M; Nunes, RG; Abreu, D; Guedes, LC; Bouça, R; Lobo, PP; Godinho, C; Coelho, M; Gonçalves, NC; Rosa, MM; Antonini, A; Ferreira, JJ;
PUBLISHED: 2017, SOURCE: JOURNAL OF PARKINSONS DISEASE, VOLUME: 7, ISSUE: 3
384
TITLE: The era of the novel oral anticoagulants in Portugal
AUTHORS: Caldeira, D; Ferreira, JJ; Pinto, FJ;
PUBLISHED: 2017, SOURCE: REVISTA PORTUGUESA DE CARDIOLOGIA, VOLUME: 36, ISSUE: 7-8
AUTHORS: Caldeira, D; Ferreira, JJ; Pinto, FJ;
PUBLISHED: 2017, SOURCE: REVISTA PORTUGUESA DE CARDIOLOGIA, VOLUME: 36, ISSUE: 7-8
INDEXED IN: 
WOS
WOS IN MY: 
ORCID
ORCID385
TITLE: Occupational pesticide exposure and penetrance of LRRK2 Parkinson's disease (PD) Full Text
AUTHORS: Tanner, C; Marras, C; Marder, K; Bressman, S; Alcalay, R; Saunders Pullman, R; Meng, CC; Gold Man, S; Korell, M; Luciano, MS; Tolosa, E; Schuele, B; Langston, JW; Brice, A; Mellick, G; Ferreira, J; Tazir, M; Klein, C; Berg, D; Lang, A;
PUBLISHED: 2017, SOURCE: MOVEMENT DISORDERS, VOLUME: 32
AUTHORS: Tanner, C; Marras, C; Marder, K; Bressman, S; Alcalay, R; Saunders Pullman, R; Meng, CC; Gold Man, S; Korell, M; Luciano, MS; Tolosa, E; Schuele, B; Langston, JW; Brice, A; Mellick, G; Ferreira, J; Tazir, M; Klein, C; Berg, D; Lang, A;
PUBLISHED: 2017, SOURCE: MOVEMENT DISORDERS, VOLUME: 32
INDEXED IN: WOS
WOS IN MY: ORCID
ORCID386
TITLE: Response of non-motor symptoms to levodopa in late-stage Parkinson's disease: Results of a levodopa challenge test Full Text
AUTHORS: Fabbri, M; Coelho, M; Guedes, LC; Chendo, I; Sousa, C; Rosa, MM; Abreu, D; Costa, N; Godinho, C; Antonini, A; Ferreira, JJ;
PUBLISHED: 2017, SOURCE: PARKINSONISM & RELATED DISORDERS, VOLUME: 39
AUTHORS: Fabbri, M; Coelho, M; Guedes, LC; Chendo, I; Sousa, C; Rosa, MM; Abreu, D; Costa, N; Godinho, C; Antonini, A; Ferreira, JJ;
PUBLISHED: 2017, SOURCE: PARKINSONISM & RELATED DISORDERS, VOLUME: 39
387
TITLE: Fifteen Years of Clinical Trials in Huntington's Disease: A Very Low Clinical Drug Development Success Rate
AUTHORS: Travessaa, AM; Rodrigues, FB; Mestre, TA; Ferreira, JJ;
PUBLISHED: 2017, SOURCE: JOURNAL OF HUNTINGTONS DISEASE, VOLUME: 6, ISSUE: 2
AUTHORS: Travessaa, AM; Rodrigues, FB; Mestre, TA; Ferreira, JJ;
PUBLISHED: 2017, SOURCE: JOURNAL OF HUNTINGTONS DISEASE, VOLUME: 6, ISSUE: 2
388
TITLE: Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression Profiles (vol 11, e157852, 2016) Full Text
AUTHORS: Pinho, R; Guedes, LC; Soreq, L; Lobo, PP; Mestre, T; Coelho, M; Rosa, MM; Gonçalves, N; Wales, P; Mendes, T; Gerhardt, E; Fahlbusch, C; Bonifati, V; Bonin, M; Miltenberger Miltényi, G; Borovecki, F; Soreq, H; Ferreira, JJ; Outeiro, TF;
PUBLISHED: 2017, SOURCE: PLOS ONE, VOLUME: 12, ISSUE: 12
AUTHORS: Pinho, R; Guedes, LC; Soreq, L; Lobo, PP; Mestre, T; Coelho, M; Rosa, MM; Gonçalves, N; Wales, P; Mendes, T; Gerhardt, E; Fahlbusch, C; Bonifati, V; Bonin, M; Miltenberger Miltényi, G; Borovecki, F; Soreq, H; Ferreira, JJ; Outeiro, TF;
PUBLISHED: 2017, SOURCE: PLOS ONE, VOLUME: 12, ISSUE: 12
INDEXED IN: WOS
WOS IN MY: ORCID
ORCID389
TITLE: New therapeutic strategies in Huntington's disease Full Text
AUTHORS: Ferreira, JJC;
PUBLISHED: 2017, SOURCE: EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 24
AUTHORS: Ferreira, JJC;
PUBLISHED: 2017, SOURCE: EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 24
INDEXED IN: WOS
WOS IN MY: ORCID
ORCID390
TITLE: Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study
AUTHORS: Davina Hensman H Moss; Sarah J Tabrizi; Simon Mead; Kitty Lo; Antonio F Pardiñas; Peter Holmans; Lesley Jones; Douglas Langbehn; Blair R Leavitt; Raymund Roos; Raymund Roos; Alexandra Durr; Alexandra Durr; Bardinet E.; Jauff J Ret; Justo D.; Lehericy S.; Marelli C.; Nigaud K.; Valabrègue R.; ...More
PUBLISHED: 2017, SOURCE: The Lancet Neurology, VOLUME: 16, ISSUE: 9
AUTHORS: Davina Hensman H Moss; Sarah J Tabrizi; Simon Mead; Kitty Lo; Antonio F Pardiñas; Peter Holmans; Lesley Jones; Douglas Langbehn; Blair R Leavitt; Raymund Roos; Raymund Roos; Alexandra Durr; Alexandra Durr; Bardinet E.; Jauff J Ret; Justo D.; Lehericy S.; Marelli C.; Nigaud K.; Valabrègue R.; ...More
PUBLISHED: 2017, SOURCE: The Lancet Neurology, VOLUME: 16, ISSUE: 9
